Overview

A Study of BMS-562086 in Patients With Irritable Bowel Syndrome

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the effects of BMS-562086 on small bowel and colonic transits in female subjects with diarrhea-predominant irritable bowel syndrome (D-IBS)
Phase:
Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb